Clinical Trial Update: Combination Chemotherapy Plus Fluoxetine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial update evaluating the combination of chemotherapy with fluoxetine for advanced or recurrent non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Fluoxetine (Fluoxetine)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Anxiety Disorder, Depression | Phase 2 | Status: COMPLETED